Gå offline med appen Player FM !
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up for Busy Scientists
«
»
105: From Proteins to Cell Therapy: Why ATMPs Aren't Just Complex Biologics with Oliver Kraemer - Part 1
Manage episode 449708290 series 3525243
In this eye-opening episode, we explore the intricate landscape of Advanced Therapy Medicinal Products (ATMPs) with Oliver Kraemer, a technical development leader at Flagship Pioneering.
Drawing from his extensive experience at industry giants like BMS, Sanofi, and Boehringer Ingelheim, Oliver challenges conventional wisdom about automation in cell and gene therapy while illuminating the crucial differences between biologics and ATMPs.
Key Takeaways for Biotech Scientists:
- Discover why automation isn't the ultimate solution for advancing CGT development right now, and what this means for your process development strategy
- Learn how ATMP development requires a fundamental rethinking of the traditional research-to-development pipeline
- Understand the critical early-stage decisions in cell therapy development that can make or break your project timeline
Join us as Oliver shares invaluable insights from his journey from traditional biologics to cutting-edge cell therapies, including both iPSC-derived and donor-derived approaches. Whether you're a bioprocess developer, cell therapy researcher, or biotech professional, this episode offers practical wisdom for navigating the complex landscape of ATMP development.
Ready to transform your understanding of cell therapy development? Listen now to gain insights that could save you months or even years in your development timeline.
Connect with Oliver Kraemer:
LinkedIn: https://www.linkedin.com/in/oliver-kraemer
Next Steps:
Wondering how to develop cell and gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop cell and gene therapies better, faster, at a fraction of the cost with our Fractional CTO services. Curious? Learn more at https://bruehlmann-consulting.com
109 episoder
Manage episode 449708290 series 3525243
In this eye-opening episode, we explore the intricate landscape of Advanced Therapy Medicinal Products (ATMPs) with Oliver Kraemer, a technical development leader at Flagship Pioneering.
Drawing from his extensive experience at industry giants like BMS, Sanofi, and Boehringer Ingelheim, Oliver challenges conventional wisdom about automation in cell and gene therapy while illuminating the crucial differences between biologics and ATMPs.
Key Takeaways for Biotech Scientists:
- Discover why automation isn't the ultimate solution for advancing CGT development right now, and what this means for your process development strategy
- Learn how ATMP development requires a fundamental rethinking of the traditional research-to-development pipeline
- Understand the critical early-stage decisions in cell therapy development that can make or break your project timeline
Join us as Oliver shares invaluable insights from his journey from traditional biologics to cutting-edge cell therapies, including both iPSC-derived and donor-derived approaches. Whether you're a bioprocess developer, cell therapy researcher, or biotech professional, this episode offers practical wisdom for navigating the complex landscape of ATMP development.
Ready to transform your understanding of cell therapy development? Listen now to gain insights that could save you months or even years in your development timeline.
Connect with Oliver Kraemer:
LinkedIn: https://www.linkedin.com/in/oliver-kraemer
Next Steps:
Wondering how to develop cell and gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop cell and gene therapies better, faster, at a fraction of the cost with our Fractional CTO services. Curious? Learn more at https://bruehlmann-consulting.com
109 episoder
Alla avsnitt
×Välkommen till Player FM
Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.